Sema4 (Formerly Known as Mount Sinai Genomics, INC. (D/B/A Sema4))
Clinical genetic testing services
Based in CT
AI Overview
With $128K in lobbying spend across 22 quarterly filings, Sema4 (Formerly Known as Mount Sinai Genomics, INC. (D/B/A Sema4)) is an active lobbying client. Their lobbying covers 5 issue areas. Active from 2019 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2019 | $45K |
| 2020 | $16K |
| 2021 | $45K |
| 2022 | $23K |
| 2023 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Sema4 (Formerly Known as Mount Sinai Genomics, INC. (D/B/A Sema4)) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Copyright/Patent, Health Issues, Medicare/Medicaid, Taxation
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Draft Guidance: Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeu
No bill #, reforming Sec. 101 of the Patent Act
Innovation in precision medicine
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.